DIFFERENCES OF BONE REGENERATION USING BOVINE HYDROXYAPATITE AND BOVINE HYDROXYAPATITE WITH FREEZE-DRIED PLATELET RICH PLASMA ALLOGRAFT IN BONE DEFECT OF FEMORAL WHITE RABBIT
Background: Hydroxyapatite is a bone graft that has osteoconductive properties for bone defects treatment. Platelet-rich plasma (PRP) has a capability of providing many bioactive molecules in physiological proportions. Hydroxyapatite given freeze-dried PRP is expected to create a graft that can strengthen the matrix while promoting osteoinduction. This study compares the effects of regeneration on the bone between bovine hydroxyapatite (BHA) and bovine hydroxyapatite with freeze-dried platelet-rich plasma (FD-PRP) as a bone graft in bone defect of the femoral white rabbit.
Methods: The 12 equal New Zealand white rabbits aged 6-9 months are divided into two groups. Bone defects were made in the lower femoral meta-diaphysis with a diameter of 2.5 mm. The defects were filled with BHA with FD-PRP allograft in the treatment group and BHA in the control group. Both groups will be sacrificed in the third and sixth weeks, then evaluated histologically for microvascular structure, osteoblasts, woven bone, type-I collagen, osteocalcin, alkaline phosphatase, and immunoglobulin G.
Results: During the evaluation in week 3 and 6, microvascular structure, osteoblast, and type-I collagen decreased in both groups with insignificant differences (p>0.05). Woven bone, osteocalcin, and immunoglobulin G increased in the treatment group but was not significant (p>0.05). Alkaline phosphatase increased higher in the treatment group, with a considerable difference in the sixth week (p=0.008).
Conclusion: The elevation in the production of woven bone, osteocalcin, and alkaline phosphatase at the third and sixth-week evaluations highlight the possibility that administering BHA given FD-PRP may have contributed to the healing of bone defects.
Brydone AS, Meek D, MacLaine S. Bone grafting, orthopaedic biomaterials, and the clinical need for bone engineering. Proc Inst Mech Eng Part H J Eng Med. 2010;224(12):1329–43.
Bowland P, Ingham E, Jennings L, Fisher J. Review of the biomechanics and biotribology of osteochondral grafts used for surgical interventions in the knee. Proc Inst Mech Eng Part H J Eng Med. 2015 Nov 24;229(12):879–88.
Jones JR, Lin S, Yue S, Lee PD, Hanna J V, Smith ME, et al. Bioactive glass scaffolds for bone regeneration and their hierarchical characterisation. Proc Inst Mech Eng Part H J Eng Med. 2010 29; 224(12): 1373–87.
Turnbull G, Clarke J, Picard F, Riches P, Jia L, Han F, Li B, Shu W. 3D bioactive composite scaffolds for bone tissue engineering. Bioactive materials. 2018 Sep 1;3(3):278-314.
Henkel J, Woodruff MA, Epari DR, Steck R, Glatt V, Dickinson IC, et al. Bone regeneration based on tissue engineering conceptions—a 21st century perspective. Bone Res. 2013; 1(1): 216–48.
Nandi SK, Roy S, Mukherjee P, Kundu B, De DK, Basu D. Orthopaedic applications of bone graft & graft substitutes: A review. Indian J Med Res. 2010; 132(7): 15–30.
Myeroff C, Archdeacon M. Autogenous bone graft: Donor sites and techniques. J Bone Jt Surg - Ser A. 2011; 93(23): 2227–36.
Gleeson JP, Plunkett NA, O’Brien FJ. Addition of hydroxyapatite improves stiffness, interconnectivity and osteogenic potential of a highly porous collagen-based scaffold for bone tissue regeneration. Eur Cell Mater. 2010; 20(218): 30.
Ngoc N. Basic Knowledge of Bone Grafting; 2012.
Venkatesan J, Kim S-K. Nano-hydroxyapatite composite biomaterials for bone tissue engineering - A review. J Biomed Nanotechnol. 2014; 10(10): 3124–40.
Hung NN. Basic knowledge of bone grafting. Zorzi A Bone Grafting Croat InTech, Chapters. 2012; 11–38.
Platt JL, Cascalho M, Piedrahita JA. Xenotransplantation: Progress Along Paths Uncertain from Models to Application. ILAR J. 2018; 59(3): 286–308.
Rivera-Muñoz EM. Hydroxyapatite-based materials: synthesis and characterization. Biomedical Engineering-Frontiers and Challenges. 2011 Aug 1:75-98.
Mahyudin F, Rantam FA. Regenerasi pada Massive Bone Defect dengan Bovine Hydroxyapatite sebagai Scaffold Mesenchymal Stem Cell. J Biosains Pascasarj. 2011; 13(3): 179–95.
Lubkowska A, Dolegowska B, Banfi G. Growth factor content in PRP and their applicability in medicine. J Biol Regul Homeost Agents. 2012 Apr 1;26(2 Suppl 1):3S-22S..
L Sinclair K, Mafi P, Mafi R. The use of growth factors and mesenchymal stem cells in orthopaedics: in particular, their use in fractures and non-unions: a systematic review. Curr Stem Cell Res Ther. 2017; 12(4): 312–25.
Qiao Z, Greven J, Horst K, Pfeifer R, Kobbe P, Pape H-C, et al. Fracture healing and the underexposed role of extracellular vesicle-based cross talk. Shock Inj Inflammation, Sepsis Lab Clin Approaches. 2018; 49(5): 486–96.
Kloping YP, Desnantyo AT, Rehatta NM. The effects of Platelet-Rich-Plasma (PRP) injection on ligament injury. Bali Med J. 2016; 5(1): 36–42.
Kasten P, Vogel J, Geiger F, Niemeyer P, Luginbühl R, Szalay K. The effect of platelet-rich plasma on healing in critical-size long-bone defects. Biomaterials. 2008; 29(29): 3983–92.
Nakatani Y, Agata H, Sumita Y, Koga T, Asahina I. Efficacy of freeze-dried platelet-rich plasma in bone engineering. Arch Oral Biol. 2017; 73: 172–8.
Rachmawati T, Astuti SP. The Effect of Allogenic Freeze Dried Platelet- Rich Plasma in Immunological Responses of Rabbits. J Stem Cell Res Tissue Eng. 2017; 1(1): 325–7.
Jensen SS, Terheyden H. Bone augmentation procedures in localized defects in the alveolar ridge: clinical results with different bone grafts and bone-substitute materials. In: Database of Abstracts of Reviews of Effects (DARE): Quality-Assessed Reviews. Centre for Reviews and Dissemination (UK); 2009.
Devescovi V, Leonardi E, Ciapetti G, Cenni E. Growth factors in bone repair. Chir Organi Mov. 2008; 92(3): 161–8.
Herrmann M, Klitscher D, Georg T, Frank J, Marzi I, Herrmann W. Different kinetics of bone markers in normal and delayed fracture healing of long bones. Clin Chem. 2002; 48(12): 2263–6.
Wesseling-Perry K, Salusky IB. Chronic kidney disease: mineral and bone disorder in children. In: Seminars in nephrology. Elsevier; 2013. p. 169–79.
Marchelli D, Piodi LP, Corradini C, Parravicini L, Verdoia C, Ulivieri FM. Increased serum OPG in atrophic nonunion shaft fractures. J Orthop Traumatol. 2009; 10(2): 55–8.
Moghaddam A, Müller U, Roth HJ, Wentzensen A, Grützner PA, Zimmermann G. TRACP 5b and CTX as osteological markers of delayed fracture healing. Injury. 2011; 42(8): 758–64.
Jacobsen G, Easter D. Allograft vs. xenograft: Practical considerations for biologic scaffolds. Musculoskelet Transpl Found; 2008.
Dumitrescu AL. Bone grafts and bone graft substitutes in periodontal therapy. In: Chemicals in surgical periodontal therapy; 2011, p. 73-144.
Baino F. Biomaterials and implants for orbital floor repair. Acta biomaterialia. 2011 Sep 1;7(9):3248-66.
Copyright (c) 2020 JOINTS (Journal Orthopaedi and Traumatology Surabaya)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
1. By submitting the article to Journal Orthopaedi and Traumatology Surabaya (JOINTS), the author has agreed to transfer some of the copyrights to the publisher of the Journal Orthopaedi and Traumatology Surabaya (JOINTS), Faculty of Medicine, Universitas Airlangga, indicated in the Copyright Transfer Agreement JOINTS.
2. Authors still retain significant rights to use and share their own published articles for non-commercial purposes subject to Creative Commons Attribution-Non Commercial-Share Alike 4.0 International License (CC BY-NC-SA)
3. All publications (printed/electronic) are open access for educational purposes, research, library, and other non-commercial purposes. Besides the purposes mentioned above, the editorial board is not responsible for copyright violations.